Companies: 48,687 Total Market Cap: 126813242788645.21

Zoetis

NYSE: ZTS
Healthcare Drug Manufacturers - Specialty & Generic
Rank #277
Market Cap 70.13 B
Volume 1.00 M
Price 157.23
Change (%) 1.02%
Country or region United States United States

Zoetis's latest marketcap:

70.13 B

As of May 2, 2025, Zoetis's market capitalization has reached $70.13 B. According to our data, Zoetis is the 277th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 70.13 B
Revenue (ttm) 9.26 B
Net Income (ttm) 2.49 B
Shares Out 446.06 M
EPS (ttm) 5.47
Forward PE 26.00
Ex-Dividend Date April 21, 2025
Earnings Date May 6, 2025
Market Cap Chart
Data Updated: May 2, 2025

Zoetis's yearly market capitalization.

Zoetis has seen its market value grow from $16.35 B to $68.77 B since 2013, representing a total increase of 320.72% and an annual compound growth rate (CAGR) of 13.53%.
Date Market Cap Change (%)
April 28, 2025 $68.77 B -6.45%
December 31, 2024 $73.51 B -18.88%
December 29, 2023 $90.62 B 32.67%
December 30, 2022 $68.30 B -40.84%
December 31, 2021 $115.46 B 46.79%
December 31, 2020 $78.66 B 24.78%
December 31, 2019 $63.04 B 53.39%
December 31, 2018 $41.10 B 17.07%
December 29, 2017 $35.10 B 32.79%
December 30, 2016 $26.43 B 10.79%
December 31, 2015 $23.86 B 10.61%
December 31, 2014 $21.57 B 31.98%
December 31, 2013 $16.35 B

Company Profile

About Zoetis Inc.

Zoetis Inc. is a global leader in animal health, specializing in the discovery, development, manufacture, and commercialization of a wide range of veterinary products and services.

Product Offerings

  • Medicines & Vaccines: Parasiticides, vaccines, dermatology treatments, anti-infectives, pain management, and sedation products.
  • Diagnostics: Point-of-care diagnostic tools, rapid immunoassay tests, reference lab services, and blood glucose monitors.
  • Non-Pharmaceutical Solutions: Nutritionals, biodevices, genetic tests, and precision animal health technologies.

Target Markets

Zoetis serves a diverse range of species, including:

  • Livestock: Cattle, swine, poultry, fish, and sheep.
  • Companion Animals: Dogs, cats, and horses.

Key Partnerships & Collaborations

The company collaborates with Blacksmith Medicines, Inc. to develop novel antibiotics for animal health.

Company Background

Founded in 1950, Zoetis is headquartered in Parsippany, New Jersey, and markets its products to veterinarians, livestock producers, and pet owners worldwide.

Frequently Asked Questions

As of May 2, 2025, Zoetis (including the parent company, if applicable) has an estimated market capitalization of $70.13 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Zoetis global market capitalization ranking is approximately 277 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1952
IPO Date February 1, 2013
Employees n/a
CEO Kristin Peck
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 10 Sylvan Way
Parsippany, New Jersey 07054
United States
People Also Watch
ETR-MRK
141.14 1.02%
NSE-SUNPHARMA
21.64 1.02%
LON-HLN
529.44 1.02%
TAK
15.33 1.02%